| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |